The Procter & Gamble Company PG, also referred to as P&G, enters fiscal 2027 with a sizable earnings hurdle. Management expects 1% to 3% organic sales growth, but higher costs, financing expense, lower non-operating income and currency are set to weigh on profit growth.

Those pressures total about $1.4 billion after tax, or 56 cents per share, equal to an 8% drag on fiscal 2026 core EPS. Productivity and brand investment will determine how much of that burden P&G can absorb.

The largest headwind is an estimated $1 billion after tax from higher raw-material, energy, transportation and related costs. Much of the pressure is expected in the first half of fiscal 2027.

Management expects this cost dynamic to contribute to a decline of at least 5% in first-quarter fiscal 2027 EPS. The outlook assumes an effective Brent crude oil price of about $90 per barrel and reflects higher freight, supplier inflation and other supply-chain premiums.

Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Procter & Gamble Company (The) Price, Consensus and EPS Surprise

Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote

P&G expects higher net interest expense to reduce fiscal 2027 earnings by about $150 million after tax. Lower non-operating income is expected to create another $150 million drag.

Unfavorable foreign exchange is projected to reduce earnings by roughly $50 million after tax. Together with input costs, these items produce the estimated $1.4 billion after-tax headwind.

P&G generated about $2.8 billion of before-tax productivity improvement across cost of goods sold and selling, general and administrative expenses in fiscal 2026. Those savings equaled roughly 340 basis points and helped fund investment.

The company is also scaling Supply Chain 3.0, AI-enabled brand-building tools and automated workflows. Colgate-Palmolive Company CL is using productivity while maintaining elevated advertising investment, while Kimberly-Clark Corporation KMB has cited productivity gains as an offset to pricing, cost inflation and supply-chain investment. Efficiency remains a key lever across consumer staples.

P&G expects fiscal 2027 all-in and organic sales to rise 1% to 3%. The organic sales outlook includes a 30-50-basis-point drag from brand, product-form and go-to-market discontinuations.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Zacks estimates call for sales growth of 1.8% in fiscal 2027. Management is targeting organic growth modestly ahead of the markets in which it competes, though slower conditions in North America and Europe limit the cushion for execution shortfalls.

P&G plans to maintain spending behind product superiority, packaging and brand communication even as costs rise. That approach supports its growth model but can restrain near-term margin expansion.

The fiscal fourth quarter showed that trade-off. Core operating margin declined 130 basis points as 410 basis points of reinvestment, primarily in marketing, more than offset 300 basis points of selling, general and administrative productivity savings. Total productivity savings reached 460 basis points.

P&G's fiscal 2027 outlook leaves productivity, pricing and execution carrying much of the burden against a meaningful earnings headwind. Core EPS is still expected to range from unchanged to up 3% from fiscal 2026, implying $6.89 to $7.11 per share.

PG currently carries a Zacks Rank #4 (Sell), alongside a Growth Score of C, Value Score of D, Momentum Score of D and VGM Score of D. The Zacks Rank points to weaker near-term earnings-estimate trends, while the Style Scores indicate limited support from growth, value and momentum characteristics. Together, they favor a cautious near-term view without determining the stock's longer-term outcome.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Procter & Gamble Company (The) (PG) : Free Stock Analysis Report

Kimberly-Clark Corporation (KMB) : Free Stock Analysis Report

Colgate-Palmolive Company (CL) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).